Listar por autor "Corma-Gómez, Anaïs"
Mostrando ítems 1-3 de 3
-
A metagenome-wide association study of HIV disease progression in HIV controllers.
Real-Navarrete, Luis Miguel
; Saéz, María E; Corma-Gómez, Anaïs; González-Pérez, Antonio; Thorball, Christian; Ruiz, Rocío; Jiménez-León, María Reyes; González-Serna, Alejandro; Gasca-Capote, Carmen; Bravo-Romero, María José; Royo-Sánchez-Palencia, José Luis; Pérez-Gómez, Alberto; Camacho-Sojo, María Inés; Gallego, Isabel; Joana, Vitalle; Bachiller, Sara; Gutierrez-Valencia, Alicia; Vidal, Francisco; Fellay, Jacques; Lichterfeld, Mathias; Ruiz-Mateos, Ezequiel[et al.] (Elsevier, 2023)
Some HIV controllers experience immunologic progression with CD4+ T cell decline. We aimed to identify genetic factors associated with CD4+ T cell lost in HIV controllers. A total of 561 HIV controllers were included, 442 ... -
Incidence of and factors associated with SARS-CoV-2 infection among people living with HIV in Southern Spain after one year of pandemic
Fernández-Fuertes, Marta; Corma-Gómez, Anaïs; Torres, Eva; Rodriguez-Pineda, Elena; Fuentes-López, Ana; Rincon, Pilar; Fernández, Nieves; García, Federico; Bernal, Samuel; Real-Navarrete, Luis Miguel; Macías, Juan; Pineda, Juan A.[et al.] (Wiley, 2021-08-17)
Whether people living with HIV (PLWH) are at greater risk of acquiring SARS-CoV-2 infection is currently unknown. Prospective serologic studies may allow seroincidence analyses, where all infections are accurately identified. ... -
The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study).
Martín-Sierra, Carmen; Bravo-Romero, María José; Saez, Maria Eugenia; De Rojas, Itziar; Santos, Marta; Martín-Carmona, Jesica; Corma-Gómez, Anaïs; González-Serna, Alejandro; Royo-Sánchez-Palencia, José Luis; Pineda, Juan A.; Rivero, Antonio; Rivero-Juárez, Antonio; Macías, Juan; Real-Navarrete, Luis Miguel[et al.] (Elsevier, 2024)
Background & aims It has been reported that specific killer-cell immunoglobulin-like receptors (KIRs) and HLA genotype combinations, such as KIR2DS4/HLA-C1 with presence of KIRDL2 or KIRDL3, homozygous KIRDL3/HLA-C1 and ...